Natco Pharma Limited Anastrozole Export Data — India (DGFT 2022–2026)

Name: Natco Pharma Limited Anastrozole Export Records India — #5 Exporter, 68 Shipments, $2.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Anastrozole

India Pharmaceutical Trade Intelligence

$110.7M158 Suppliers99 CountriesHS 30049099

ExportsIndia → UNITED STATES92.3%India → BRAZIL1.9%

ImportsUNITED STATES → India$10.5M ISRAEL → India$2.0M

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: EVERSANA LIFE

Natco Pharma Limited — Anastrozole Exporter #5 | $2.7M Trade Value | TransData Nexus | TransData Nexus

Natco Pharma Limited — Anastrozole Exporter Profile

Indian Pharmaceutical Exporter · #5 for Anastrozole · $2.7M export value · DGFT Verified

Natco Pharma Limited is the #5 Indian exporter of Anastrozole with $2.7M in export value and 68 verified shipments. Natco Pharma Limited holds a 2.4% market share in Anastrozole exports across 10 countries. The company exports 17 pharmaceutical products worth $36.0M across 6 therapeutic categories.

Natco Pharma Limited — Anastrozole Export Profile: Buyers & Destinations

Natco Pharma Limited Anastrozole export treemap — buyers and destination countries | TransData Nexus

Where Does Natco Pharma Limited Export Anastrozole?

Country	Value	Shipments	Share
CANADA	$409.2K	23	42.3%
UNITED KINGDOM	$204.1K	6	21.1%
UNITED STATES	$200.0K	4	20.7%
GERMANY	$121.1K	9

Who Are the Top Buyers of Anastrozole from Natco Pharma Limited?

Buyer	Country	Value	Orders
MARCAN PHARMACEUTICALS INC	CANADA	$240.2K	11
BRECKENRIDGE PHARMACEUTICAL INC	UNITED STATES	$150.0K	3
LEXON UK LIMITED	UNITED KINGDOM	$150.0K	3
MARCAN PHARMACEUTICALS INC,	CANADA	$122.0K	4
LEXON (UK) LIMITED	UNITED KINGDOM	$54.1K	3
XXECKXXRIDXX PHXXMACXXTICXX IXX	UNITED STATES	$50.0K	1
HEUMANN PHARMA GMBH & CO.	GERMANY	$41.1K	3
HEUNET PHARMA GMBH	GERMANY	$33.4K	2
NATCO PHARMA (CANADA) INC	CANADA	$28.5K	4
HEUNET PHARMA GMBH AND CO GENERICA KG	GERMANY	$24.4K	1

Natco Pharma Limited supplies Anastrozole to 21 buyers globally. The largest buyer is MARCAN PHARMACEUTICALS INC (CANADA), followed by BRECKENRIDGE PHARMACEUTICAL INC (UNITED STATES) and LEXON UK LIMITED (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Anastrozole Formulations Does Natco Pharma Limited Export?

Product Description / Formulation	Value	Shipments
ANASTROZOLE TABLETS USP 1MG - BT	$100.0K	2
ANASTROZOLE 1MG TABLETS 28S (QTY.108160X28'S=3028480 NOS)(RODTEP ENTRY NO.10112)(OTHER REF CI NO.123277)NOS	$54.1K	3
ANASTROZOLE TABLETS 1MG 30'S (15200X30'S	$50.0K	1
ANASTROZOLE TABLET USP 1 MG BT90'S	$50.0K	1
ANASTROZOLE TABLETS 1MG 30'S 17230 X 30'S PACK OTHER REF CI NO:123169 RODTEP ENTRY NO: 10112	$50.0K	1
ANASTROZOLE TABLETS USP, 1MG BT 30'S	$50.0K	1
ANASTROZOLE 1MG TABLETS 30'S (12570X30'S)(APPENDIX 4R, RODTEP ENTRY NO:10112)(OTHER REFERENCE(S)CI NO:123279)	$50.0K	1
ANASTROZOLE 1MG TABLETS 28'S (QTY.107855X28'S=3019940 NOS)(RODTEP ENTRY NO.10112)(OUR REF CI NO.124053)	$50.0K	1
ANASTROZOLE 1MG TABLETS 28'S (QTY.166570X28'S=4663960 NOS)(RODTEP ENTRY NO.10112)(OUR REF CI NO.125006)	$50.0K	1
ANASTROZOLE 1MG TABLETS 28'S (QTY.165104X28'S=4622912 NOS)(RODTEP ENTRY NO.10112)(OUR REF CI NO.125005)	$50.0K	1

Natco Pharma Limited exports 60 distinct Anastrozole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ANASTROZOLE TABLETS USP 1MG - BT with 2 shipments worth $100.0K.

How Does Natco Pharma Limited Compare to Nearest Anastrozole Exporters?

Exporters ranked immediately above and below #5 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	EUGIA PHARMA SPECIALITIES LIMITED	$3.5M	116	6	$30.4K
4	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$3.1M	70	5	$44.9K
5	NATCO PHARMA LIMITED ★	$2.7M	68	10	$39.5K
6	JODAS EXPOIM PRIVATE LIMITED	$1.2M	24	3	$50.0K
7	CADILA HEALTHCARE LTD	$450.0K	9	1	$50.0K

Natco Pharma Limited ranks #5 among 158 Indian Anastrozole exporters. Average shipment value of $39.5K compared to the market average of $163.1K. The closest competitors by value are EUGIA PHARMA SPECIALITIES LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED.

Which Indian Ports Ship Anastrozole Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	465	20.8%
SAHAR AIR	391	17.5%
DELHI AIR CARGO ACC (INDEL4)	280	12.5%
DELHI AIR	167	7.5%
MUNDRA SEA	90	4.0%
Bombay Air	86	3.8%
HYDERABAD AIR	75	3.4%
MUNDRA SEA (INMUN1)	70	3.1%

Geopolitical & Trade Policy Impact on Natco Pharma Limited's Anastrozole Exports

Natco's export operations are currently navigating a complex geopolitical landscape. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. These challenges are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management. (pharmaceuticalcommerce.com)

In the United States, recent tariff implementations have introduced additional complexities for Indian pharmaceutical exporters. The U.S. administration's imposition of tariffs on imports from various countries, including India, has raised concerns about the competitiveness of Indian generics in the U.S. market. These tariffs could potentially erode profit margins and affect pricing strategies. (apnews.com)

Conversely, the European Union's stringent regulatory changes, such as the Falsified Medicines Directive, have heightened compliance requirements for exporters. While these regulations aim to ensure product authenticity and safety, they also necessitate significant investments in serialization and traceability systems. For companies like Natco, adhering to these standards is crucial for maintaining access to the lucrative EU market.

Natco Pharma Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing intensified scrutiny regarding quality and compliance. The U.S. Food and Drug Administration (FDA) has increased inspections of Indian manufacturing facilities, emphasizing adherence to Good Manufacturing Practices (GMP). Non-compliance can lead to warning letters, import alerts, or even bans, posing significant risks to exporters. (fact.net.in)

Natco's commitment to quality is evident in its proactive measures to meet international standards. The company's recent product approvals and successful market entries suggest a robust compliance framework. However, continuous vigilance and investment in quality systems are imperative to navigate the evolving regulatory landscape and to sustain export growth.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Anastrozole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Natco Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 68 individual customs records matching Natco Pharma Limited exporting Anastrozole, covering 60 formulations to 10 countries via 21 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 99+ countries, 387+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Anastrozole

Anastrozole

Natco Pharma Limited — Anastrozole Exporter Profile

Natco Pharma Limited — Anastrozole Export Profile: Buyers & Destinations

Where Does Natco Pharma Limited Export Anastrozole?

Who Are the Top Buyers of Anastrozole from Natco Pharma Limited?

What Is India's Total Anastrozole Export Value and How Much Does Natco Pharma Limited Contribute?

What Is the Average Shipment Value for Natco Pharma Limited's Anastrozole Exports?

How Does Natco Pharma Limited Compare to Other Indian Anastrozole Exporters?

What Anastrozole Formulations Does Natco Pharma Limited Export?

Regulatory Requirements: Exporting Anastrozole to Key Markets

Canada — HC

United Kingdom — MHRA

United States — FDA

How Does Natco Pharma Limited Compare to Nearest Anastrozole Exporters?

Which Indian Ports Ship Anastrozole Exports?

What Other Advanced Oncology Products Does Natco Pharma Limited Export?

Anastrozole — Export Intelligence Video

Geopolitical & Trade Policy Impact on Natco Pharma Limited's Anastrozole Exports

Natco Pharma Limited — Regulatory Compliance & Quality Standards

About Natco Pharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Anastrozole Export Data from Natco Pharma Limited

Anastrozole Stats

Company Overview

Top Products by Natco Pharma Limited

Related Analysis

Need Detailed Export Data?

Data Source